Oppenheimer Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $601K | Sell |
16,995
-14,200
| -46% | -$578K | 0.01% | 837 |
|
|
2025
Q4 | $1.27M | Sell |
31,195
-5,210
| -14% | -$227K | 0.02% | 621 |
|
|
2025
Q3 | $1.71M | Buy |
36,405
+1,178
| +3% | +$61.1K | 0.02% | 609 |
|
|
2025
Q2 | $1.83M | Sell |
35,227
-836
| -2% | -$45.9K | 0.02% | 585 |
|
|
2025
Q1 | $2.18M | Buy |
36,063
+4,734
| +15% | +$305K | 0.03% | 496 |
|
|
2024
Q4 | $2.14M | Sell |
31,329
-3,535
| -10% | -$246K | 0.03% | 508 |
|
|
2024
Q3 | $2.51M | Sell |
34,864
-176
| -0.5% | -$12.4K | 0.03% | 477 |
|
|
2024
Q2 | $2.43M | Buy |
35,040
+7,239
| +26% | +$528K | 0.03% | 475 |
|
|
2024
Q1 | $2.23M | Sell |
27,801
-4,763
| -15% | -$425K | 0.03% | 450 |
|
|
2023
Q4 | $3.57M | Sell |
32,564
-816
| -2% | -$84.4K | 0.05% | 375 |
|
|
2023
Q3 | $3.37M | Sell |
33,380
-245
| -0.7% | -$28.2K | 0.05% | 365 |
|
|
2023
Q2 | $4.57M | Sell |
33,625
-2,732
| -8% | -$334K | 0.07% | 300 |
|
|
2023
Q1 | $3.78M | Buy |
36,357
+4,348
| +14% | +$420K | 0.06% | 331 |
|
|
2022
Q4 | $2.84M | Sell |
32,009
-833
| -3% | -$69.1K | 0.05% | 391 |
|
|
2022
Q3 | $2.63M | Buy |
32,842
+781
| +2% | +$73.7K | 0.05% | 387 |
|
|
2022
Q2 | $3.07M | Sell |
32,061
-1,092
| -3% | -$131K | 0.05% | 366 |
|
|
2022
Q1 | $4.92M | Sell |
33,153
-432
| -1% | -$60.3K | 0.07% | 299 |
|
|
2021
Q4 | $4.76M | Buy |
33,585
+1,879
| +6% | +$266K | 0.06% | 319 |
|
|
2021
Q3 | $4.15M | Buy |
31,706
+89
| +0.3% | +$11.6K | 0.06% | 341 |
|
|
2021
Q2 | $4.34M | Buy |
31,617
+1,314
| +4% | +$180K | 0.06% | 330 |
|
|
2021
Q1 | $3.96M | Buy |
30,303
+2,945
| +11% | +$354K | 0.06% | 328 |
|
|
2020
Q4 | $3.06M | Buy |
27,358
+4,502
| +20% | +$426K | 0.05% | 370 |
|
|
2020
Q3 | $1.8M | Buy |
+22,856
| New | +$1.86M | 0.03% | 456 |
|
|
2020
Q1 | – | Sell |
-81
| Closed | -$9K | – | 1523 |
|
|
2019
Q4 | $9K | Hold |
81
| – | – | ﹤0.01% | 1506 |
|
|
2019
Q3 | $8K | Buy |
81
+16
| +25% | +$1.5K | ﹤0.01% | 1510 |
|
|
2019
Q2 | $6K | Buy |
+65
| New | +$5.34K | ﹤0.01% | 1545 |
|
|
2018
Q3 | – | Sell |
-3,067
| Closed | -$225K | – | 1144 |
|
|
2018
Q2 | $225K | Sell |
3,067
-2,131
| -41% | -$145K | 0.01% | 1039 |
|
|
2018
Q1 | $329K | Buy |
5,198
+712
| +16% | +$42.5K | 0.01% | 906 |
|
|
2017
Q4 | $235K | Hold |
4,486
| – | – | 0.01% | 1002 |
|
|
2017
Q3 | $235K | Sell |
4,486
-1
| -0% | -$50 | 0.01% | 1007 |
|
|
2017
Q2 | $229K | Sell |
4,487
-81
| -2% | -$4.01K | 0.01% | 998 |
|
|
2017
Q1 | $203K | Buy |
+4,568
| New | +$196K | 0.01% | 1043 |
|
Other funds holding CNMD
VPM
VCM
CB
Oppenheimer Asset Management's CNMD Position: Q1 2026 in Review
Oppenheimer Asset Management reduced its CONMED (CNMD) stake by 46% in Q1 2026, selling an estimated $578K and leaving 16,995 shares worth $601K. The position accounts for 0.01% of the portfolio, ranked #837.
Oppenheimer Asset Management first reported a position in CNMD in Q1 2017 and has held it in 32 quarters since. The position peaked at $4.92M in Q1 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Oppenheimer Asset Management held 16,995 shares of CONMED worth $601K as of Q1 2026.
- Oppenheimer Asset Management sold 14,200 CONMED shares in Q1 2026, an estimated $578K.
- CONMED made up 0.01% of Oppenheimer Asset Management's portfolio in Q1 2026, its #837 holding.
- Oppenheimer Asset Management first reported a position in CONMED in Q1 2017 and has held it in 32 quarters since.
- Oppenheimer Asset Management's CONMED position peaked at $4.92M in Q1 2022.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Oppenheimer Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.